News and Trends 7 Nov 2022Scancell in-licenses Vaccitech’s SNAPvax tech for cancer study Scancell Holdings plc, a developer of immunotherapies, today (November 7) announced it has in-licensed the SNAPvax technology from Vaccitech plc,… November 7, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email